IPSE allows Intellectual Property owners to sell current and future authoring and neighbouring royalties on the stock market.
IPSE is ideal positioned to manage IP securities for Music and Movie securitization for example. This patented business method was developed over the last decade by the company’s founder Marc Deschenaux. It works in the same way as pass-through securities, whereby monthly payments due are collected by a servicing intermediary on a pool of assets, this intermediary collects from the issuer after deduction of a handling fee and then passes them through to the holders of the security. The whole process begins by securitizing IP rights that guarantees that holders of these instruments are ensured payments on the royalties rights of the works that these IP rights cover. By listing them on the NASDAQ, trades will be concluded between IP owners and investors. From music production to the distribution and sale of tickets or the collection of royalties, IPSE covers the full life cycle of the IP's current and future value.
IPSE solution can be used to finance top-end Hollywood movies with a minimum all-in cost of $40 million, thereby insuring a successful financing with direct access to the public markets. The company also intends to follow the trend and capitalize on the mega-movie projects with a budget over $100 million.
From Copyrights to Patent Rights
To go public on the NASDAQ and create a new asset class of securities is the result of more than a decade of hard work and expertise from our team. We created the only solution to support and invest, with strong tax benefits, in Art and Science directly."
Marc Deschenaux, IPSE founder and CEO
Innovation and the need for a new generation of securities to finance art, culture and science have been our main reason to invest in IPSE. My group of investors are proud to be the main contributor to the future success of this remarkable business."
Eric Marcozzi, IPSE - Final round of investors representative
For Erfisa S.A. it is really exciting to invest in such an innovative equity like approach. The growth perspectives of the company coupled to the need that IPSE fulfills makes this opportunity a good fit in our search for investments that have an impact on world of tomorrow."
Mathias Rasandimanana Erfisa Director
For Swiss Financiers, to be able to orchestrate the IPO of such an innovative company on the NASDAQ is a major challenge and its success a demonstration of the high expertise required to manage and organise this complex IPO."
Alex Kummerman - Swiss Financiers Founding Partner
Intellectual Property Securities Corporation is an American company that was founded by Philippe Froehlicher, Richard Ormond and Marc Deschenaux in December 2014. It is specialized in the securitization of intellectual property and offers an innovative and patented method accompanied by the toolset to finance any form of production. With IPSE the founders developed a securitization system that increases the control of authors, artists, inventors, or other IP holders over their IP rights, which has never existed before in the strict form. The founders and their team are convinced that IP securitization is necessary and that it will financially help to sustain research and creative projects. The process of securitization designed by IPSE will generate new funds for authors and inventors resulting from the assignment of the securities on the private and public markets. The synergy of IP rights into securities and their management by IPSE will remove the risk of loss of royalties relative to the works of the author.
Intellectual Property Securities Corp is specialized in the securitization of intellectual property, offering an innovative and patented method and toolset to finance about any form of production. From music production to the distribution and sale of shows ticket, we cover the full life cycle of IP value
Swiss Financiers is managed by a group of entrepreneurs and experts that have a proven track record in finance, innovation, start-up funding, governance, management and leadership. Its team has a vast historic experience in financial affairs and banking. Each of the founding partners has a distinctive background from specialized yet complimentary sectors of the industry. Swiss Financiers has expertise in areas such as: investments, venture capital, private equity, debt, securities and investment banking. Collectively, the team came to the same conclusion that business and investment banks approach were too complex and too expensive to correctly serve the majority of companies in need of support. The team is committed to innovative IPOs financing solutions and supporting companies when they need it and not when they are successful.
Swiss Financiers Team Has :
- Listed 179 IPOs on major securities markets. Some key IPOs include Nestscape, Starbucks or Wix.
- Orchestrated Debt and/or Mezzanine Capital Financing for USD 2B+
- An active deal flow of 6 companies ready to go public
- A current mandate to establish a strategic SPAC
- Developed Patent Pending Business Methods to accelerate and improve the process of IPO
- An active and strong network of brokers dealers with access accredited investors looking for private placement opportunities
Swiss Financiers team :
- Supports companies through its network of mentors and active investors that typically includes providing expert Board of Director participation and guiding senior management
- Assists incubated companies with transactional financing activities such as private investments, secondary offerings, debt financing, etc and leverages its extensive active investment banking relationships
- Is a dealmaker between incubated companies, industry leaders and executives worldwide, fast tracking successful transactions with investment banks, institutional investors and debt lenders.
Interview in person of Mr Marc Deschenaux, IPSE Founder and Patent author, is possible at the Harvard Club of New York until Friday feb 5th. Interview requests are to be made directly with Mr Deschenaux.
Contact : firstname.lastname@example.org
+41 79 231 54 67
+41 79 574 50 16